Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in NSCLC? A propensity score matching analysis

• Yang Pan,
• Xuanhong Jin,
• Yuqi Lin,
• Jian Zeng

Affiliations

Yang Pan

Department of Pulmonary Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences

Xuanhong Jin

Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University

Yuqi Lin

Department of Pulmonary Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences

Jian Zeng

Department of Pulmonary Surgery, Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences